According to government data, the PM Narendra Modi government has supplied over 68 lakh tablets of the anti-TB drug Bedaquiline and over 9 lakh tablets of Delamanid across India.
There is no dearth of anti-TB drugs in India. Bharati Pravin PawarThe Minister of State (MoS) for Health and Family Welfare, sharing the data on drug supply between April 1, 2021 and March 28, 2022, told the Rajya Sabha.
Last year, various parts of the country reported that stocks of Delaminid, a key patented drug used in the treatment of drug-resistant tuberculosis (DR-TB), were out of stock.
Shortage of such drugs may hamper the government’s target TB eradication by 2025 – five years ahead 2030. global goal of – Besides causing hardship and life threatening to the patients.
Under the National TB Elimination Program (NTEP), all drugs are provided free of charge.
“There is no dearth of drugs bedaquiline and delamanid in the country including the state of Bihar,” Pawar said on March 29 in response to a question by politician Manoj Kumar Jha.
She also clarified: “There is no short supply of the diagnostic kits needed to detect rifampicin-resistant tuberculosis In the country, including the state of Bihar. ,
Asked whether Delamanid is costly and efforts have been made to introduce generic versions from domestic manufacturers, Pawar said: “Delamanid has been procured at Rs 140 per tablet, while the global price is around Rs 190 per tablet. “
The Minister clarified that not only for adults, but also the pediatric formulation of Bedaquiline has been made available to the States. He added, however, that the pediatric formulation for delamanid is not approved for use in India and is therefore not available.
read all breaking news , today’s fresh news And IPL 2022 Live Updates Here.